An Organometallic Compound which Exhibits a DNA Topology-Dependent One-Stranded Intercalation Mode.

Understanding how small molecules interact with DNA is essential since it underlies a multitude of pathological conditions and therapeutic interventions. Many different intercalator compounds have been studied because of their activity as mutagens or drugs, but little is known regarding their interaction with nucleosomes, the protein-packaged form of DNA in cells. Here, using crystallographic methods and molecular dynamics simulations, we discovered that adducts formed by [(η(6) -THA)Ru(ethylenediamine)Cl][PF6 ] (THA=5,8,9,10-tetrahydroanthracene; RAED-THA-Cl[PF6 ]) in the nucleosome comprise a novel one-stranded intercalation and DNA distortion mode. Conversely, the THA group in fact remains solvent exposed and does not disrupt base stacking in RAED-THA adducts on B-form DNA. This newly observed DNA binding mode and topology dependence may actually be prevalent and should be considered when studying covalently binding intercalating compounds.

[1]  G. Davey,et al.  Stereochemical control of nucleosome targeting by platinum-intercalator antitumor agents , 2015, Nucleic acids research.

[2]  U. Rothlisberger,et al.  Mixed Quantum Mechanical/Molecular Mechanical Molecular Dynamics Simulations of Biological Systems in Ground and Electronically Excited States. , 2015, Chemical reviews.

[3]  U. Rothlisberger,et al.  Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity , 2014, Nature Communications.

[4]  A. Rescifina,et al.  Recent advances in small organic molecules as DNA intercalating agents: synthesis, activity, and modeling. , 2014, European journal of medicinal chemistry.

[5]  G. Davey,et al.  The mechanics behind DNA sequence-dependent properties of the nucleosome , 2012, Nucleic acids research.

[6]  G. Davey,et al.  Specific DNA structural attributes modulate platinum anticancer drug site selection and cross-link generation , 2011, Nucleic acids research.

[7]  P. Dyson,et al.  A ruthenium antimetastasis agent forms specific histone protein adducts in the nucleosome core. , 2011, Chemistry.

[8]  P. Sadler,et al.  Penetrative DNA intercalation and G-base selectivity of an organometallic tetrahydroanthracene RuII anticancer complex , 2010 .

[9]  C. Davey,et al.  Structural insight into the sequence dependence of nucleosome positioning. , 2010, Structure.

[10]  U. Surana,et al.  DNA stretching in the nucleosome facilitates alkylation by an intercalating antitumour agent , 2009, Nucleic acids research.

[11]  J. Barton,et al.  Metallo-intercalators and metallo-insertors. , 2007, Chemical communications.

[12]  T. Richmond,et al.  DNA stretching and extreme kinking in the nucleosome core. , 2007, Journal of molecular biology.

[13]  Colin G. Barry,et al.  Platinum-intercalator conjugates: from DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation. , 2004, Current topics in medicinal chemistry.

[14]  J. Cummings,et al.  In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer , 2002, British Journal of Cancer.

[15]  P. Sadler,et al.  Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts. , 2002, Journal of the American Chemical Society.

[16]  S. Lippard,et al.  2.4 A crystal structure of an oxaliplatin 1,2-d(GpG) intrastrand cross-link in a DNA dodecamer duplex. , 2001, Inorganic chemistry.

[17]  P. Sadler,et al.  Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity. , 2005, Chemistry & biology.